If Medicare is going to cover CBD products, you can bet it will be done in a way that mirrors other pilot drug programs that have been rolled out in the past. First, the products will have to get the green light from the FDA that means they'll need to show they're safe, have standard dosing, and that they actually work. The criteria for approval will be pretty clear: products will have to show they're safe, consistent, and necessary for medical treatment. Don't count on Medicare covering OTC CBD products only those that are prescribed by a doctor will qualify. The real challenge here is going to be figuring out how to regulate these products. You can't just slap a label on them and hope for the best - they need clear labeling, controlled sources, and a way to track how well they're working before we can start talking about broad coverage.
I think the government will most likely use FDA data to select the products if this pilot program is implemented. FDA-approved drugs are currently exclusively covered by Medicare Part D plans, and I don't see them easily altering this fundamental rule. Prescription-grade CBD would probably be the first to be introduced. Instead of merely promoting general wellness, companies would have to demonstrate that their product truly treats a particular medical condition, such as epilepsy or chronic pain. Strict manufacturing standards would be necessary to guarantee that the bottle truly contains what is stated on the label. Today's shelves are filled with mislabeled goods, and the government detests having to pay for unidentified ingredients. Manufacturers would likely be required by this pilot to submit lab results with precise THC levels and zero heavy metals. Medicare may add a product to the formulary tiers if it passes those tests and reduces opioid prescriptions.